Active Ingredient (In Each Softgel)
Docusate Sodium 250 mg
The following Structured Product Label (SPL) was submitted to the FDA by Avpak for the product Docusate Sodium (NDC 50268-268). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each softgel), purpose, keep out of reach of children., uses, do not use:, ask a doctor before use, stop use and ask a doctor, if you are pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Sodium 250 mg
Stool Softener
In case of overdose, get medical help or contact a Poison Control Center right away.
if you notice a sudden change in bowel habits that persists over a period of two weeks.
if you have rectal bleeding or you fail to have a bowel movement after use.
ask a healthcare professional before use.
| Adults and Children over 12 years of age | Take orally 1 softgel preferably at bedtime for
2-3 days or until bowel movements are normal, or as directed by a doctor. |
| Children under 12 years of age | Do not use this product for children under 12 years of age, unless directed by a doctor. |
FD&C Red #40, FD&C Yellow #6, Gelatin, Glycerin, Ink (Edible), Polyethylene Glycol, Propylene Glycol, Purified Water, Sorbitol
Call 1-855-361-3993
NDC 50268-268-15
AvKARE
Docusate Sodium, USP
Stool Softener
250 mg Each
100 Softgels
USA
AV Rev. 05/16 (P)
Manufactured for:
AvKARE, Inc.
Pulaski, TN 38478
* Please review the disclaimer below.